T-Cell Response to Vaccination | Clinical Research Studies Listing

Recruiting

18 years - 65 years

All

Phase N/A

Brief description of study

The purpose of this study is to see how your body responds to a vaccine and how your body forms a protective response after vaccination. In this study we will use the yellow fever vaccine, an FDA approved vaccine that is commonly given to people traveling to certain parts of Africa and South America.

Detailed description of study

The study consists of a screening visit followed by 9 study visits. From the time of screening, you will be in this study for between 8-12 months. The study include: Screening visit (approx 1 hour), Study visit 1 - Luekopheresis (approx 2.5 hours), Study Visit 2 - Vaccination (approx 45 mins), Study Visits 3-8 - Blood Draws (approx 30 mins), Study Visit 9 - Leukopheresis (approx 2.5 hours).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: healthy Volunteers,healthy subjects,Healthy,Healthy volunteer,healthy,healthy volunteer,healthy volunteers,healthy subjects,healthy
Age: 18 years - 65 years
Gender: All

Updated on 10 Dec 2025. Study ID: 820884

Pre-Screener

Compruebe si es elegible Ingrese los datos de contacto Selecciona un centro de estudios Select best time to contact

Are you between the ages of 18 and 65?

None

Yes No

Preview complete

The prescreener preview is complete. You may now close the preview.